In previous study, Debio 1562, a potent antibody–drug conjugate directed at CD37, was demonstrated to suppress the proliferative capacities of AML cell lines, including OCI-AML3, THP-1 and primary AML samples. The gene discussed is RUNX2; the disease is acute myeloid leukemia.